Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?

被引：77
|
作者：
Berasain, Carmen [1 ]
机构：
[1] Univ Navarra, CIMA, Div Hepatol & Gene Therapy, Pamplona 31008, Spain
来源：
GUT | 2013年 / 62卷 / 12期
关键词：
Drug Resistance; Gene Targeting; Hepatocellular Carcinoma; Liver; Molecular Carcinogenesis; CELLS;
D O I：
10.1136/gutjnl-2013-304564
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1674 / 1675
页数：2
相关论文
共 50 条
  • [1] Mechanisms of sorafenib resistance in hepatocellular carcinoma
    Liang, Yuanjing
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)
  • [2] Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
    Zhai, Bo
    Sun, Xue-Ying
    WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (07) : 345 - 352
  • [3] Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
    Bo Zhai
    Xue-Ying Sun
    World Journal of Hepatology, 2013, (07) : 345 - 352
  • [4] Sorafenib for hepatocellular carcinoma: potential molecular targets and resistance mechanisms
    Dahiya, Mandeep
    Dureja, Harish
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (05) : 286 - 301
  • [5] The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
    Weiwei Tang
    Ziyi Chen
    Wenling Zhang
    Ye Cheng
    Betty Zhang
    Fan Wu
    Qian Wang
    Shouju Wang
    Dawei Rong
    F. P. Reiter
    E. N. De Toni
    Xuehao Wang
    Signal Transduction and Targeted Therapy, 5
  • [6] The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
    Tang, Weiwei
    Chen, Ziyi
    Zhang, Wenling
    Cheng, Ye
    Zhang, Betty
    Wu, Fan
    Wang, Qian
    Wang, Shouju
    Rong, Dawei
    Reiter, F. P.
    De Toni, E. N.
    Wang, Xuehao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [7] Molecular mechanisms of HCG18 in the sorafenib resistance of hepatocellular carcinoma
    Li, Heping
    Hu, Jie
    Qiu, Lijie
    Wu, Yijiang
    Zhong, Baiyin
    Ye, Rong
    Xie, Binhui
    ANTI-CANCER DRUGS, 2024, 35 (01) : 55 - 62
  • [8] Elucidation of the molecular mechanisms mediating sorafenib-resistance in Hepatocellular carcinoma
    Vishnoi, Kanchan
    Ke, Rong
    Kumar, Randhir
    Viswakarma, Navin
    Rana, Ajay
    Rana, Basabi
    CANCER RESEARCH, 2020, 80 (16)
  • [9] Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma
    Lin, Haoming
    Zhang, Rui
    Wu, Wenrui
    Lei, Liming
    CANCER GENETICS, 2020, 245 : 27 - 34
  • [10] New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies
    Niu, Leilei
    Liu, Liping
    Yang, Shengli
    Ren, Jianwei
    Lai, Paul B. S.
    Chen, George G.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017, 1868 (02): : 564 - 570
12345